Shoshana Shendelman - Jan 11, 2023 Form 4 Insider Report for Applied Therapeutics Inc. (APLT)

Signature
/s/ Shoshana Shendelman
Stock symbol
APLT
Transactions as of
Jan 11, 2023
Transactions value $
-$14,442
Form type
4
Date filed
1/13/2023, 03:34 PM
Previous filing
Oct 14, 2022
Next filing
Sep 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Sale -$14.4K -15.9K -2.07% $0.91 752K Jan 11, 2023 Direct F1
transaction APLT Common Stock Award $0 +1.96M +261.35% $0.00 2.72M Jan 11, 2023 Direct F2, F3
holding APLT Common Stock 1.75M Jan 11, 2023 See footnote F4
holding APLT Common Stock 1.49M Jan 11, 2023 See footnote F5
holding APLT Common Stock 710K Jan 11, 2023 See footnote F6
holding APLT Common Stock 290K Jan 11, 2023 See footnote F7
holding APLT Common Stock 88.4K Jan 11, 2023 See footnote F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
F2 Includes 1,725,000 compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on January 11, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each month thereafter, subject to the reporting person continuing to provide services through each such date.
F3 Includes 239,362 compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. The issuer determined to make this compensatory grant of Restricted Stock Units to the reporting person in lieu of a cash bonus that otherwise would have been paid with respect to 2022. All of the shares subject to the compensatory Restricted Stock Units vested immediately upon grant.
F4 Through a grantor retained annuity trust.
F5 Through a family trust controlled by the reporting person's spouse.
F6 Through the reporting person's spouse.
F7 Through a family trust controlled by the reporting person.
F8 Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.

Remarks:

The reporting person has agreed to voluntarily disgorge to the Issuer all statutory "profits" pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended, that resulted from the transactions reported herein.